Naproxen Sodium And Diphenhydramine Hcl 11673-0819
Product NDC
11673-0819- Manufacturer
- Target Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA213663
Active Ingredients
| Ingredient | Strength |
|---|---|
| Diphenhydramine Hydrochloride | 25 mg/1 |
| Naproxen Sodium | 220 mg/1 |
Drug Class
Anti-Inflammatory AgentsNon-Steroidal [CS]Cyclooxygenase Inhibitors [MoA]
Packaging Options(1)
80 TABLET in 1 BOTTLE (11673-819-08)